Acute Lymphoblastic Leukaemia

Hispanic individuals appeared considerably underrepresented in a large clinical trial of adolescents and young adults with acute lymphoblastic leukemia, according to study results presented at ASH Annual Meeting and Exposition.

Ten years ago, researchers at NCI reported use of CD19-directed chimeric antigen receptor T-cell therapy that successfully induced remission in a patient with follicular lymphoma.

Use of a modified pediatric protocol produced favorable outcomes for adolescents and young adults with acute lymphoblastic leukemia, according to retrospective study results presented at Society of Hematologic Oncology Annual Meeting.